We are live on
!
Find out more
NICM
Neo Ivy Capital Management Portfolio holdings
AUM
$379M
1-Year Est. Return
28.34%
This Fund
S&P 500
This Quarter
Est. Return
-28.43%
1 Year Est. Return
+28.34%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$61.4M
AUM Growth
-$25.1M
(-29%)
Cap. Flow
-$72.2K
Cap. Flow
% of AUM
-0.12%
Top 10 Holdings %
Top 10 Hldgs %
8.67%
Holding
587
New
335
Increased
38
Reduced
76
Closed
138
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWO
Two Harbors Investment
TWO
|
+$1.02M |
| 2 |
Alaska Air
ALK
|
+$909K |
| 3 |
SLB Ltd
SLB
|
+$900K |
| 4 |
Trane Technologies
TT
|
+$768K |
| 5 |
American Financial Group
AFG
|
+$760K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$733K |
| 2 |
Dentsply Sirona
XRAY
|
+$704K |
| 3 |
Fidelity National Financial
FNF
|
+$703K |
| 4 |
United Parcel Service
UPS
|
+$703K |
| 5 |
IBM
IBM
|
+$702K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.11% |
| 2 | Industrials | 15.54% |
| 3 | Technology | 14.65% |
| 4 | Consumer Discretionary | 12.33% |
| 5 | Healthcare | 11.13% |
Similar funds
MC
ACA
AFCM
DAL
SFWC
FP
C
HCP
Neo Ivy Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Neo Ivy Capital Management held 587 positions worth $61.4M, down 29% from $86.5M the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Neo Ivy Capital Management's Q1 2020 filing shows 335 new, 38 increased, 76 reduced and 138 closed positions. Its largest new stake was Two Harbors Investment: 20,048 shares worth $306K. The largest sale was Gilead Sciences, an estimated $733K.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 14% a quarter earlier, followed by Industrials and Technology.
- Neo Ivy Capital Management's largest Q1 2020 buy was Two Harbors Investment: 20,048 shares worth $306K.
- Neo Ivy Capital Management added most to Trane Technologies in Q1 2020, an estimated $768K increase.
- Neo Ivy Capital Management's biggest Q1 2020 reduction was Gilead Sciences, cutting an estimated $733K.
- Neo Ivy Capital Management fully exited Dentsply Sirona in Q1 2020, selling an estimated $704K.
- Neo Ivy Capital Management's ten largest holdings make up 8.7% of its $61.4M portfolio in Q1 2020.
- Neo Ivy Capital Management opened 335 new positions and closed 138 in Q1 2020.
- Neo Ivy Capital Management's portfolio value fell 29% quarter-over-quarter to $61.4M.
Based on Neo Ivy Capital Management's 13F filing for Q1 2020, filed 15 May 2020.